November 18, 2025

Vesalio Aspiration Devices FDA Cleared for Peripheral and Neurovascular Thrombectomy

November 18, 2025—Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, advancing the company’s goal to provide a complete suite of thrombectomy products across multiple vascular territories.

According to the company, the devices integrate aspiration technology with the company’s flagship mechanical retrieval platform, powered by the Vesalio Drop Zone and microfiltration technologies, for efficient clot removal.

These clearances are a milestone in the company’s evolution toward a fully integrated thrombectomy ecosystem, where mechanical retrieval and aspiration technologies work in synergy to enhance procedural efficiency and clinical success, noted the press release.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

November 18, 2025

Vesalio Aspiration Devices FDA Cleared for Peripheral and Neurovascular Thrombectomy

Current Issue

Keep In Touch